Impax Asset Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-349,816
Closed -$21.4M 201
2017
Q3
$21.4M Hold
349,816
1.22% 24
2017
Q2
$21.4M Buy
349,816
+30,533
+10% +$1.86M 1.21% 26
2017
Q1
$19.4M Buy
319,283
+8
+0% +$485 1.08% 29
2016
Q4
$17.9M Sell
319,275
-53,677
-14% -$3.14M 1.02% 34
2016
Q3
$22.2M Buy
372,952
+8
+0% +$468 1.27% 19
2016
Q2
$20.5M Buy
372,944
+7
+0% +$373 1.19% 25
2016
Q1
$18.8M Sell
372,937
-209,624
-36% -$10.3M 1.01% 37
2015
Q4
$29.4M Sell
582,561
-41,766
-7% -$2.11M 1.63% 8
2015
Q3
$29.4M Buy
624,327
+94,351
+18% +$5.01M 1.75% 7
2015
Q2
$28.8M Buy
529,976
+20
+0% +$1.12K 1.54% 10
2015
Q1
$29.1M Buy
529,956
+10,453
+2% +$592K 1.59% 11
2014
Q4
$28.2M Buy
519,503
+17
+0% +$947 1.67% 12
2014
Q3
$29.4M Buy
519,486
+215,164
+71% +$12.1M 1.91% 8
2014
Q2
$16.8M Buy
304,322
+167,833
+123% +$9.16M 1.06% 38
2014
Q1
$7.39M Buy
+136,489
New +$7.07M 0.47% 63

Other funds holding MRK

Impax Asset Management's MRK Position: Q4 2017 in Review

Impax Asset Management sold out of Merck (MRK) in Q4 2017, closing a stake of 349,816 shares — an estimated $21.4M sold.

Impax Asset Management first reported a position in MRK in Q1 2014 and held it in 15 quarters. The position peaked at $29.4M in Q3 2015. 2,008 funds tracked by Wall St. Rank hold MRK as of Q4 2017.

  • Impax Asset Management reported no remaining Merck position as of Q4 2017 after selling out during the quarter.
  • Impax Asset Management sold 349,816 Merck shares in Q4 2017, an estimated $21.4M.
  • Impax Asset Management first reported a position in Merck in Q1 2014 and held it in 15 quarters.
  • Impax Asset Management's Merck position peaked at $29.4M in Q3 2015.
  • 2,008 funds tracked by Wall St. Rank held Merck as of Q4 2017.

Based on Impax Asset Management's 13F filing for Q4 2017, filed 14 Feb 2018.